Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain

  1. Martínez, C.
  2. Carpio, C.
  3. Heras, I.
  4. Ríos-Herranz, E.
  5. Buch, J.
  6. Gutierrez, A.
  7. Romero, S.
  8. Zeberio, I.
  9. García-García, I.
  10. Rodriguez-Izquierdo, A.
  11. Alonso, R.
  12. Bargay, J.
  13. Barrenetxea, C.
  14. Domingo-Doménech, E.
  15. de Haro, M.E.
  16. Palomera, L.
  17. García-Sanz, R.
Aldizkaria:
Biology of Blood and Marrow Transplantation

ISSN: 1523-6536,  1083-8791

Argitalpen urtea: 2020

Alea: 26

Zenbakia: 8

Orrialdeak: 1534-1542

Mota: Artikulua

DOI: 10.1016/J.BBMT.2020.02.003 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak